# SriSai Biopharmaceutical Solutions LLC – FDA Inspection, Feb 23, 2023

Source: https://www.keypedia.com/records/fda_inspections/srisai-biopharmaceutical-solutions-llc/66799cbe-df8a-49e7-9955-022702023f84
Source feed: FDA_Inspections

> FDA inspection 1198226 of SriSai Biopharmaceutical Solutions LLC, February 23, 2023. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR parts 211 and 212. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1198226
- Company Name: SriSai Biopharmaceutical Solutions LLC
- Inspection Date: 2023-02-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 8

## Related Documents

- [FDA Inspection 682156 - 2010-09-24](https://www.keypedia.com/records/fda_inspections/srisai-biopharmaceutical-solutions-llc/3e4fba7e-5840-4861-954e-bbd257156ffe)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/marcellinus-d-dordunoo/a0e35c24-0cf5-4b11-95ba-1693fa3ecb3a)
- [FDA Associated Person](https://www.keypedia.com/people/pushpa-s-jayasekara/cfd7d22f-b4c2-4002-ae18-b5435815d27d)

Company: https://www.keypedia.com/companies/srisai-biopharmaceutical-solutions-llc/405b4534-a3e0-4233-8fad-9b18efa713b1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
